Which antiplatelet agent is known to be an IV administration drug?

Eptifibatide is an antiplatelet agent that is specifically administered intravenously. It belongs to a class of drugs known as glycoprotein IIb/IIIa inhibitors, which work by blocking the platelet receptor responsible for aggregation. This intravenous route allows for rapid onset of action, making it particularly useful in acute settings such as during percutaneous coronary interventions (PCI) or in the management of acute coronary syndromes.

Other antiplatelet agents like ticagrelor and clopidogrel are typically administered orally, highlighting the distinct route of administration associated with eptifibatide. Warfarin, while an anticoagulant, functions differently and is also given orally, emphasizing the specific role and functionality of eptifibatide as an IV drug in acute clinical scenarios.